Insights

Sep 14th, 2026

News

Why phase 2 decisions are locking out pharma’s best launch positions

Read Article

Aug 12th, 2026

Press Release

Treating phase 2 study design as a scientific decision is compromising launch performance, warns expert

Read Article

Aug 12th, 2026

News

Why Clinical Data Isn’t Enough: What the GLP-1 Payer Wars Teach Us About Commercialisation Strategy

Read Article

Jun 19th, 2026

News

From North Star to market success: Nmblr launches Explore to sharpen biopharma commercialisation strategy

Read Article

Jun 11th, 2026

News

How to build a commercialisation strategy fit for biopharma’s new evidence era

Read Article

May 14th, 2026

News

How to close your insight gaps ahead of the patent cliff crisis

Read Article

Apr 30th, 2026

News

Nmblr successfully achieves ISO/IEC 27001 certification

Read Article

Apr 14th, 2026

News

Insight gaps leave Biopharma vulnerable to patent cliff crisis, warns expert

Read Article

Feb 24th, 2026

News

U.S. Biopharma focus: 7 steps to unlock worldwide access

Read Article